Boule Diagnostics Quits Hematology Instruments After Chinese Price War: Shares Jump 40 Percent
· techtimes.com · popularity 18/100 · 0 similar stories today · Entrepreneurship & Startups (Business & Finance)
Read the original at techtimes.com →
Summary
Boule Diagnostics exits hematology instruments amid Chinese competition, betting survival on 31,000 installed instruments' reagent revenue. Shares jump 40%.
Found in: Tech Times. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 12.